Advanced search
Publication Cover
Upsala Journal of Medical Sciences Volume 116, 2011 - Issue 2
Journal homepage
685
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [11C]CIT and target controlled infusion

Olof Eriksson Department of Radiology, Oncology and Radiation Sciences, Division of Radiology, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
,
Bengt Långström Department of Biochemistry and Organic Chemistry, Uppsala University, Uppsala, Sweden
&
Ray Josephsson Clinical Imaging Unit, Novartis Pharma AG, Basel, Switzerland
Pages 100-106 | Received 25 Oct 2010, Accepted 12 Feb 2011, Published online: 28 Mar 2011

References

  • Eriksson O, Wallberg A, Syvänen S, Josephsson R, Långström B, Bergström M. A computerized infusion pump for control of tissue tracer concentration during positron emission tomography in vivo pharmacokinetic/pharmacodynamic measurements. BMC Med Phys. 2008;8:2.
  • Eriksson O, Josephsson R, Långstrom B, Bergström M. Positron emission tomography and target-controlled infusion for precise modulation of brain drug concentration. Nucl Med Biol. 2008;35:299–303.
  • Syvanen S, Blomquist G, Sprycha M, Hoglund AU, Roman M, Eriksson O, Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET. Neuroimage. 200;32:1134–41.
  • Halldin C, Farde L, Lundkvist C, Ginovart N, Nakashima Y, Karlsson P, [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Synapse. 1996;22:386–90.
  • Gulley JM, Zahniser NR. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol. 2003;479:139–52.
  • Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry. 2005;57:229–38.
  • Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvalahti E, Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res. 2001;52:115–20.
  • Uhl GR. Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism. Mov Disord. 2003;18:71–80.
  • Carson RE, Channing MA, Blasberg RG, Dunn BB, Cohen RM, Rice KC. Comparison of bolus and infusion methods for receptor quantitation: Application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab. 1993;13:24–42.
  • Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab. 1997;17:437–47.
  • Carson, RE. PET physiological measurements using constant infusion. Nucl Med Bio. 2000;27:657–60.
  • Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev. 2006;12:178–207.
  • Rothman RB,Baumann M, Prisinzano TE, Newman AH. Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem Pharmacol. 2008;75:2–16.
  • Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153–8.
  • Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab. 1996;16:42–52.
  • Learned-Coughlin SM, Bergström M, Savitcheva I, Ascher J, Schmith VD, Långstrom B. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry. 2003;54:800–5.
  • Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S. Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology. 2002;163:102–5.
  • Villemagne VL, Rothman RB, Yokoi F, Rice KC, Matecka D, Dannals RF, Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans. Synapse. 1999;32:44–50.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.